These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32586771)

  • 21. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
    Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
    Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India.
    Pandey P; Kumari S; Mandal S; Setya D; Kumar P
    Transfus Clin Biol; 2022 Aug; 29(3):213-218. PubMed ID: 35667592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of a potential novel tool in virtual crossmatching for platelet transfusion in platelet refractoriness.
    Bub CB; Gonçalez AC; Barjas-Castro ML; Sousa LC; do Monte SJ; Castro V
    Vox Sang; 2016 Jan; 110(1):70-8. PubMed ID: 26274830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of microcolumn gel immunoassay in screening the platelet antibody].
    Xu DY; Dong GF; Zhang Z; Peng MX; Du Y; Chen CS; Tang XX; Fu JY; Gao JL; Bai J; Ma YL; Qian BY; Ma JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):888-91. PubMed ID: 17708827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.
    Gavva C; Barroso J; Gernsheimer T; Metcalf RA; Warner P; Pagano MB
    Transfusion; 2019 Jul; 59(7):2276-2281. PubMed ID: 31032968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies.
    Wu YF; Shen CL; Huang WH; Chu SC; Li CC; Liu CZ; Wang TF
    Int J Lab Hematol; 2024 Aug; 46(4):722-730. PubMed ID: 38682289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet crossmatches of single-donor platelet concentrates using a latex agglutination assay.
    Ogden DM; Asfour A; Koller C; Lichtiger B
    Transfusion; 1993 Aug; 33(8):644-50. PubMed ID: 8342230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM; Summers TC; Sinor LT; Plapp FV
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: solid-phase platelet crossmatching to support the alloimmunized patient.
    O'Connell BA
    Immunohematology; 1995; 11(4):150-2. PubMed ID: 15447057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive Transfusions.
    Sullivan JC; Peña JR
    Arch Pathol Lab Med; 2022 Oct; 146(10):1243-1251. PubMed ID: 35171984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors related to the outcome of prophylactic platelet transfusions in patients with hematologic malignancies: an observational study.
    Seigeot A; Desmarets M; Rumpler A; Leroux F; Deconinck E; Monnet E; Bardiaux L
    Transfusion; 2018 Jun; 58(6):1377-1387. PubMed ID: 29542122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
    Cid J; Ramiro L; Escoda L; Llorente A
    Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.